Literature DB >> 21145413

Outsourcing lead optimization: the eye of the storm.

David E Clark1.   

Abstract

This article is the third in a series examining the evolution of the market for outsourced lead optimization services and covers developments from late 2006 to the present. Following an analysis of the significant events that have impacted the marketplace in recent years, a brief survey of the growing number of companies offering lead optimization services is presented. Subsequently, three notable trends that can be perceived in this highly dynamic field are discussed: the continuing rise of outsourcing companies in Asia and Eastern Europe, the increase in deals with not-for-profit organizations and, finally, the emergence of a variety of business models under which outsourced work is conducted.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Mesh:

Year:  2010        PMID: 21145413     DOI: 10.1016/j.drudis.2010.11.012

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  2 in total

1.  Drug Discovery: Collaborations between Contract Research Organizations and the Pharmaceutical Industry.

Authors:  Victoria A Steadman
Journal:  ACS Med Chem Lett       Date:  2018-06-04       Impact factor: 4.345

Review 2.  Changing R&D models in research-based pharmaceutical companies.

Authors:  Alexander Schuhmacher; Oliver Gassmann; Markus Hinder
Journal:  J Transl Med       Date:  2016-04-27       Impact factor: 5.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.